av/aurobindo--big.svg

COM:AUROBINDO

Aurobindo Pharma

  • Stock

Last Close

1,250.10

21/11 09:59

Market Cap

772.21B

Beta: -

Volume Today

397.95K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
80.39B
-
120.43B
49.81%
136.49B
13.34%
146.64B
7.43%
161.99B
10.47%
192.26B
18.68%
192.26B
0%
245.58B
27.73%
233.67B
4.85%
233.67B
0%
290.02B
24.12%
cost of revenue
36.06B
-
55.06B
52.68%
61.58B
11.84%
64.34B
4.49%
67.53B
4.95%
87.13B
29.02%
87.13B
0%
99.02B
13.66%
101.40B
2.40%
101.40B
0%
180.47B
77.98%
gross profit
44.33B
-
65.37B
47.49%
74.92B
14.60%
82.30B
9.85%
94.46B
14.79%
105.13B
11.29%
105.13B
0%
146.55B
39.40%
132.26B
9.75%
132.26B
0%
109.54B
17.18%
selling and marketing expenses
3.99B
-
9.34B
134.02%
9.47B
1.31%
11.30B
19.43%
10.90B
3.56%
11.92B
9.36%
11.92B
0%
16.43B
37.84%
15.69B
4.55%
15.69B
0%
general and administrative expenses
989.40M
-
2.65B
167.38%
2.65B
0.07%
3.31B
25.19%
4.10B
23.61%
4.25B
3.69%
4.25B
0%
8.27B
94.71%
6.45B
22.03%
6.45B
0%
selling general and administrative expenses
4.98B
-
11.99B
140.65%
12.11B
1.04%
14.62B
20.69%
15.00B
2.60%
16.17B
7.81%
16.17B
0%
24.70B
52.78%
22.13B
10.40%
22.13B
0%
66.33B
199.67%
research and development expenses
50.90M
-
253M
397.05%
150.60M
40.47%
165.80M
10.09%
292.20M
76.24%
756.30M
158.83%
756.30M
0%
688.10M
9.02%
652.40M
5.19%
652.40M
0%
other expenses
189.90M
-
431.50M
127.22%
299.50M
30.59%
306.10M
2.20%
803.70M
162.56%
1.02B
26.76%
1.02B
0%
2.26B
121.61%
1.35B
40.40%
76.50B
5,584.85%
5.19B
93.22%
cost and expenses
61.62B
-
97.17B
57.68%
107.85B
11.00%
116.22B
7.76%
129.32B
11.27%
159.17B
23.09%
159.17B
0%
200.82B
26.16%
200.69B
0.06%
200.69B
0%
246.81B
22.98%
operating expenses
25.56B
-
42.11B
64.73%
46.28B
9.89%
51.88B
12.10%
61.79B
19.11%
72.05B
16.60%
72.05B
0%
101.79B
41.28%
99.28B
2.46%
99.28B
0%
66.33B
33.19%
interest expense
937.90M
-
708.60M
24.45%
793.30M
11.95%
545.10M
31.29%
628.90M
15.37%
1.51B
139.75%
1.51B
0%
595.70M
60.49%
368.40M
38.16%
368.40M
0%
2.90B
686.40%
ebitda
19.94B
-
26.44B
32.61%
32.18B
21.68%
35.71B
10.99%
38.89B
8.90%
40.23B
3.43%
40.23B
0%
53.78B
33.70%
46.21B
14.08%
46.21B
0%
58.43B
26.44%
operating income
18.76B
-
23.26B
23.99%
28.64B
23.13%
30.42B
6.21%
32.67B
7.41%
33.08B
1.26%
33.08B
0%
44.54B
34.61%
33.06B
25.76%
34.94B
5.69%
43.21B
23.66%
depreciation and amortization
3.13B
-
3.33B
6.42%
3.93B
18.04%
4.28B
8.92%
5.58B
30.48%
6.68B
19.71%
6.68B
0%
10.55B
58.00%
11.27B
6.74%
11.27B
0%
167.90K
100.00%
total other income expenses net
-3.44B
-
-1.58B
53.92%
-1.42B
10.48%
187.20M
113.21%
-262.40M
240.17%
-2.17B
727.36%
-2.17B
0%
28.90B
1,431.19%
663.10M
97.71%
-1.22B
283.59%
758.10M
162.27%
income before tax
15.33B
-
21.68B
41.46%
27.22B
25.58%
30.61B
12.43%
32.41B
5.89%
30.91B
4.62%
30.91B
0%
73.44B
137.55%
33.73B
54.07%
33.73B
0%
43.97B
30.37%
income tax expense
3.63B
-
5.97B
64.15%
7.44B
24.77%
7.60B
2.05%
8.18B
7.72%
7.27B
11.17%
7.27B
0%
20.10B
176.50%
7.26B
63.89%
7.26B
0%
12.11B
66.89%
net income
11.73B
-
15.76B
34.35%
19.82B
25.78%
23.02B
16.13%
24.23B
5.28%
23.65B
2.41%
28.31B
19.72%
53.35B
88.45%
26.48B
50.36%
26.48B
0%
31.73B
19.82%
weighted average shs out
582.49M
-
583.52M
0.18%
584.16M
0.11%
585.21M
0.18%
585.88M
0.11%
585.91M
0.00%
585.91M
0%
585.94M
0.01%
585.94M
0%
585.94M
0%
585.85M
0.01%
weighted average shs out dil
583.16M
-
583.77M
0.10%
584.32M
0.09%
585.22M
0.15%
585.89M
0.11%
585.94M
0.01%
585.94M
0%
585.94M
0.00%
585.94M
0%
585.94M
0%
585.85M
0.01%
eps
20.14
-
27.03
34.21%
34.67
28.26%
39.33
13.44%
41.36
5.16%
40.36
2.42%
40.36
0%
91.05
125.59%
45.19
50.37%
45.20
0.02%
54.16
19.82%
epsdiluted
20.11
-
27
34.26%
34.66
28.37%
39.33
13.47%
41.36
5.16%
40.36
2.42%
40.36
0%
91.05
125.59%
45.19
50.37%
45.20
0.02%
54.16
19.82%

All numbers in (except ratios and percentages)